Peptides are used in research as tools with a known sequence. Laboratories use short synthetic peptides to map where antibodies bind, as substrates and inhibitors in enzyme assays, as known-mass material for checking instruments and methods, and as model pieces of larger proteins in structural biology. Each job depends on knowing the exact sequence.
- A synthetic peptide's value in research comes from its exactly known sequence and calculable mass.
- Solid-phase peptide synthesis, reported by Merrifield in 1963, made custom sequences routine.
- Geysen and colleagues (1984) mapped a viral epitope to single residues using hundreds of synthesized peptides.
- Peptide substrates such as Ac-DEVD-AMC report protease activity by releasing a fluorescent group when cut.
- Peptide aldehyde inhibitors were used in 1995 to block apoptotic events in vitro in work on the protease apopain.
- Structures of proteins bound to short peptides are archived in the Protein Data Bank.
A short chain with a known order
Picture a biochemist holding a tube of white powder that cost less than lunch. Inside is a chain of maybe ten amino acids, joined in an order she chose from a keyboard the week before. She did not buy it to make anything. She bought it to ask a question, and the peptide is the question written in chemistry.
That is most of what peptides do in a laboratory. A peptide is a short chain of amino acids linked by peptide bonds, and the useful thing about a synthetic one is that its sequence is known exactly. If you know the sequence, you know the mass, you can predict roughly how it will behave on a column, and you can change one residue and see what happens. The rest of this page is a tour of the jobs that follow from that.
If the basic chemistry is new, the guides on the dipeptide and on reading a peptide sequence cover the bond and the naming. Here the interest is in what researchers actually do with the finished chain.
- Epitope mapping: overlapping peptides show where an antibody binds
- Enzyme assays: a cut peptide releases a fluorescent reporter
- Method checks: a calculable mass tests the instrument
- Structural biology: a short ligand caught in a protein structure
- Every job: identity confirmed against the sequence first
Why synthetic peptides became everyday tools
For a long time a peptide of a chosen sequence was hard to get. Chemists built chains in solution, one residue at a time, purifying after every step. In 1963 R. B. Merrifield described solid-phase peptide synthesis, in a paper titled for the synthesis of a tetrapeptide, where the growing chain stays anchored to an insoluble support while reagents are washed through.
The consequence was practical. Excess reagent and by-products could be rinsed away instead of separated by hand, so each coupling step became quicker and the whole process could be repeated reliably. Over the following decades that turned custom peptides into catalog items, and a sequence someone typed on Monday could be on a bench by the end of the week.
Cheap, exact sequences are what make the uses below possible. None of them would be worth doing if every peptide took a year to make.
Synthesis is not perfect, though. Every coupling step has a small failure rate, and a chain that misses one residue somewhere in the middle comes off the support looking a lot like the right one. Those deletion sequences are the main reason a research peptide arrives with a purity figure and a mass check attached, and the reason a careful lab reads both before it trusts the tube.
Mapping where an antibody binds
An antibody recognizes a small patch on its target, called an epitope. For many proteins part of that patch is a short run of consecutive amino acids, and that makes peptides a natural way to find it: cut the protein sequence into overlapping short pieces, make each piece, and see which ones the antibody sticks to.
Geysen, Meloen and Barteling showed how far this could go in 1984. They synthesized hundreds of peptides on solid supports and tested them against antisera by ELISA, locating an epitope on a foot-and-mouth disease virus coat protein at positions 146 to 152. Then they replaced every position in that stretch with each of the twenty amino acids in turn. That pinned the binding to individual residues, and they reported that the leucines at positions 148 and 151 were essential for the antisera to react.
The same logic still runs through a great deal of immunology research. A peptide array is a set of questions of the form does the antibody care about this residue?, answered in one plate. Peptides are also used the other way round, as the antigen against which a laboratory raises an antibody to a chosen stretch of protein, which is how many research antibodies to a specific region are made.
Substrates and inhibitors for enzyme assays
Proteases cut proteins at particular sequences. If you know the sequence an enzyme prefers, you can make a short peptide carrying it and attach a reporter group that only lights up once the bond is cut. The enzyme then tells you how active it is by producing signal you can read on a plate reader.
Ac-DEVD-AMC is a well-known example of the design: a four-residue acetylated peptide joined to a fluorescent coumarin group. PubChem lists it as C30H37N5O13 with a molecular weight of 675.6. While the peptide and the coumarin stay joined, the fluorescence stays low; cleavage after the aspartate frees the dye and the signal rises.
Change the business end and the substrate becomes an inhibitor. In 1995 Nicholson and colleagues purified the protease they named apopain, related to the enzyme ICE and to the nematode protein CED-3, and reported a potent peptide aldehyde inhibitor that blocked apoptotic events in vitro. Peptide-based substrates and inhibitors of this kind remain standard kit in protease biochemistry, because a sequence can be tuned residue by residue toward the enzyme of interest.
How are peptides used to check instruments and methods?
A peptide of known sequence has a mass that can be calculated to several decimal places before it is ever weighed. That makes it useful for checking instruments. Run it through a mass spectrometer and the observed mass either lands where the arithmetic says it should or it does not, and a miss points to calibration drift or a sample problem.
The same property matters when a laboratory writes an analytical method. ICH Q2(R2), the international guideline on validating analytical procedures, treats specificity as a test expected for identification methods: the method must be shown to respond to the analyte and not to things that look like it. Well-characterized peptide material is what such a method is developed and checked against.
Standards work comes with its own paperwork. A reference material is only as good as its documented identity and content, which is why the page on HPLC purity versus identity is worth reading alongside this one. A purity figure without an identity result does not make a peptide a standard.
Pieces of proteins in structural biology
Whole proteins can be large, floppy and hard to crystallize. A peptide lets a structural biologist study one piece: the stretch that binds a partner, the segment that folds into a helix, or the short motif an enzyme grips. Pair a protein with a peptide ligand and the complex can sometimes be solved when the protein alone would not cooperate.
The results end up in the Protein Data Bank. Its training guide describes a freely available archive holding hundreds of thousands of 3D structures of biological molecules, determined by experimental techniques including X-ray crystallography. Many entries are proteins caught holding a short peptide, and those structures show atom by atom how the two recognize each other.
Peptides also serve as simple models for the questions of folding and stability that are hard to ask of a whole protein. A twelve-residue chain can be made, varied and measured many times over in the time it takes to express and purify one large protein.
What do all of these jobs have in common?
Each use above rests on the same assumption: the material in the tube is the sequence on the label. An epitope map built with a peptide missing one residue maps the wrong thing. An enzyme assay run with a substrate half degraded underestimates activity. A calibration check with the wrong mass calibrates to an error.
That is why research peptides are judged on documentation first. Identity is usually confirmed by mass spectrometry against the calculated mass, purity by reversed-phase HPLC with its method stated, and content by a separate measurement. Our certificate index shows how a lot's paperwork is published once its certificate is issued, and the guide on research use only peptides explains the label that goes with this kind of material.
None of this involves people. The jobs described here happen in tubes, plates, columns and crystals, and that is the whole scope of the material we supply.
FOR LABORATORY AND IN-VITRO RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Common questions
What are peptides used for in a research laboratory?
How are peptides used to map epitopes?
Why do enzyme assays use short peptides as substrates?
Why does the sequence have to be confirmed before a peptide is used?
What made synthetic peptides cheap enough for routine research?
More science guides
Sources
- Geysen HM, Meloen RH, Barteling SJ. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. PNAS 1984;81(13):3998-4002. Hundreds of solid-support peptides tested by ELISA; epitope at positions 146 to 152; leucines 148 and 151 essential.
- Nicholson DW et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376:37-43. Purification of apopain and a potent peptide aldehyde inhibitor that prevented apoptotic events in vitro.
- Merrifield RB. Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. J Am Chem Soc 1963;85(14):2149-2154. The paper that introduced solid-phase synthesis.
- PubChem Compound Summary for CID 9896164, Ac-DEVD-AMC. Formula C30H37N5O13 and molecular weight 675.6 for the fluorogenic substrate.
- RCSB PDB-101, Guide to Understanding PDB Data: Introduction. Describes the PDB archive of 3D structures and the experimental methods, including X-ray crystallography.
- ICH Q2(R2), Validation of Analytical Procedures (2023). Lists specificity as a validation test for identification procedures.
